Both in Pharmaceuticals
Citius Oncology vs Nomad Power Solutions
Over the past year CTOR returned −39.6% and NMAD returned +0.6%; their daily moves had a correlation of 0.05.
CTOR −39.6% NMAD +0.6%Growth of $1, one year, split-adjusted
| Metric | CTOR | NMAD |
|---|---|---|
| Price | $0.5540 | $3.56 |
| Market cap | $58.6M | $57.3M |
| Today | +4.63% | +0.56% |
| 1 month | −43.5% | −7.8% |
| 6 months | −41.4% | — |
| Year to date | −44.6% | — |
| 1 year | −68.3% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | 67.1% | — |
| Net margin | −597.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 8.2× | — |
| Net cash | $10.2M | — |
| Dividend yield | — | — |
| Volatility (60d) | 96.7% | — |
| Short % of float | 0.8% | 11.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).